Country: United States
Language: English
Source: NLM (National Library of Medicine)
NORETHINDRONE ACETATE (UNII: 9S44LIC7OJ) (NORETHINDRONE - UNII:T18F433X4S)
AvKARE
NORETHINDRONE ACETATE
NORETHINDRONE ACETATE 5 mg
ORAL
PRESCRIPTION DRUG
Norethindrone acetate tablets, USP is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer. Norethindrone acetate tablets, USP are not intended, recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection. - Known or suspected pregnancy. There is no indication for norethindrone acetate, USP in pregnancy. (See PRECAUTIONS .) - Undiagnosed vaginal bleeding - Known, suspected or history of cancer of the breast - Active deep vein thrombosis, pulmonary embolism or history of these conditions - Active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction) - Impaired liver function or liver disease - As a diagnostic test for pregnancy - Hypersensitivity to any of the drug components
Norethindrone acetate tablets, USP, 5 mg, are supplied as white to off-white oval, biconvex tablets debossed with “AN” bisect “475” on one side and plain on the other side. They are available as follows: Bottles of 90: NDC 42291-650-90 Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
NORETHINDRONE ACETATE- NORETHINDRONE TABLET AvKARE ---------- PATIENT INFORMATION Norethindrone Acetate Tablets Read this PATIENT INFORMATION before you start taking norethindrone acetate tablets and read what you get each time you refill norethindrone acetate tablets. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition. What is the most important information I should know about norethindrone acetate (A Progestin Hormone) tablets? • Do not use norethindrone acetate if you are pregnant, breastfeeding or are trying to conceive. • Do not use norethindrone acetate if you have had a previous blood clot, stroke, or heart attack. • Do not use norethindrone acetate if you are postmenopausal. What is norethindrone acetate? Norethindrone acetate is similar to the progesterone hormones naturally produced by the body. What are norethindrone acetate tablets used for? Norethindrone acetate tablets are used for the treatment of secondary amenorrhea (absence of menstrual periods in women who have previously had a menstrual period who are not pregnant), the treatment of endometriosis, and the treatment of irregular menstrual periods due to hormone imbalance. Who should not take norethindrone acetate tablets? You should not take norethindrone acetate tablets if you are postmenopausal, pregnant or breast-feeding. You should not take norethindrone acetate tablets if you have the following conditions: • Known or suspected pregnancy. Norethindrone acetate tablets are not indicated during pregnancy as it may cause fetal harm when administered to pregnant women. There is an increased risk of minor birth defects in children whose mothers take norethindrone acetate during the first 4 months of pregnancy (mild masculinization of the external genitalia of the female fetus, as well as hypospadias in the male fetus). If you take norethindrone acetate and later find out you were pregnant, talk with your healthcare provider right away. • History of Read the complete document
NORETHINDRONE ACETATE- NORETHINDRONE TABLET AVKARE ---------- NORETHINDRONE ACETATE TABLETS, USP RX ONLY DESCRIPTION Norethindrone acetate tablets, USP - 5 mg oral tablets. Norethindrone acetate, USP (17-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one acetate), a synthetic, orally active progestin, is the acetic acid ester of norethindrone, USP. It is a white, or creamy white, crystalline powder. Norethindrone acetate tablets, USP contain the following inactive ingredients: lactose, magnesium stearate, and microcrystalline cellulose. CLINICAL PHARMACOLOGY Norethindrone acetate induces secretory changes in an estrogen-primed endometrium. On a weight basis, it is twice as potent as norethindrone. PHARMACOKINETICS _Absorption_ Norethindrone acetate is completely and rapidly deacetylated to norethindrone (NET) after oral administration, and the disposition of norethindrone acetate is indistinguishable from that of orally administered norethindrone. Norethindrone acetate is rapidly absorbed from norethindrone acetate tablets, with maximum plasma concentration of norethindrone generally occurring at about 2 hours post-dose. The pharmacokinetic parameters of norethindrone following single oral administration of norethindrone acetate in 29 healthy female volunteers are summarized in Table 1. TABLE 1.PHARMACOKINETIC PARAMETERS AFTER A SINGLE DOSE OF NORETHINDRONE ACETATE IN HEALTHY WOMEN Norethindrone Acetate (n=29) Arithmetic Mean ± SD Norethindrone (NET) AUC = area under the curve, C = maximum plasma concentration, t = time at maximum plasma concentration, t = half-life, SD = standard deviation AUC (ng/ml*h) 166.90 ± 56.28 C (ng/ml) 26.19 ± 6.19 t (h) 1.83 ± 0.58 t (h) 8.51 ± 2.19 FIGURE 1. MEAN PLASMA CONCENTRATION PROFILE AFTER A SINGLE DOSE OF 5 MG ADMINISTERED TO 29 HEALTHY FEMALE VOLUNTEERS UNDER FASTING CONDITIONS _Effect of Food_ The effect of food administration on the pharmacokinetics of norethindrone acetate has not been studied. _Distribution_ Norethindrone is 36% bound to sex hormone-binding globulin (SHBG) Read the complete document